Arthur P DeMarzo1. 1. Dermed Diagnostics Inc, 2-S 558 White Birch Lane, Wheaton, IL 60189, USA. ademarzo.dermed@att.net
Abstract
INTRODUCTION: Early detection of cardiovascular disease (CVD) in prehypertension could initiate appropriate treatment and prevent progression. Impedance cardiography (ICG) is a noninvasive technology that can be used to assess cardiovascular function. OBJECTIVE: This study used ICG waveform analysis with postural change to detect CVD in asymptomatic prehypertensive adults over 40 years of age with no history of CVD and at least 2 cardiovascular risk factors: cigarette smoking, poor diet, physical inactivity, central obesity, family history of premature CVD, elevated blood glucose, and dyslipidemia. METHODS: A study group of 25 apparently healthy adults was tested by ICG in standing and supine positions. Criteria for an age-matched control group of 16 healthy subjects included an active lifestyle, no risk factor, and no history of CVD. In addition to hemodynamic measurements of systemic vascular resistance (SVR) and cardiac index (CI), ICG used SVR to assess vascular resistive load, an index of arterial compliance and a widening of the systolic waveform to assess vascular pulsatile load, and waveform analysis and measured wave amplitude to detect ventricular dysfunction. RESULTS: All subjects in the study group had some abnormal ICG data, with an average of 2.9 ± 1.5 abnormalities per person. ICG indicated that 24 (96%) had elevated vascular load, 13 (52%) had some type of ventricular dysfunction, and 12 (48%) had abnormal hemodynamics. For the control group, ICG showed none (0%) with elevated vascular load, none (0%) with ventricular dysfunction, and 7 (44%) with high CI. CONCLUSIONS: Prehypertensives over 40 years of age with multiple risk factors have different cardiovascular abnormalities. This ICG test could be used as part of a prevention program for early detection of CVD. An abnormal ICG test could expedite the initiation of customized treatment that targets the subclinical CVD.
INTRODUCTION: Early detection of cardiovascular disease (CVD) in prehypertension could initiate appropriate treatment and prevent progression. Impedance cardiography (ICG) is a noninvasive technology that can be used to assess cardiovascular function. OBJECTIVE: This study used ICG waveform analysis with postural change to detect CVD in asymptomatic prehypertensive adults over 40 years of age with no history of CVD and at least 2 cardiovascular risk factors: cigarette smoking, poor diet, physical inactivity, central obesity, family history of premature CVD, elevated blood glucose, and dyslipidemia. METHODS: A study group of 25 apparently healthy adults was tested by ICG in standing and supine positions. Criteria for an age-matched control group of 16 healthy subjects included an active lifestyle, no risk factor, and no history of CVD. In addition to hemodynamic measurements of systemic vascular resistance (SVR) and cardiac index (CI), ICG used SVR to assess vascular resistive load, an index of arterial compliance and a widening of the systolic waveform to assess vascular pulsatile load, and waveform analysis and measured wave amplitude to detect ventricular dysfunction. RESULTS: All subjects in the study group had some abnormal ICG data, with an average of 2.9 ± 1.5 abnormalities per person. ICG indicated that 24 (96%) had elevated vascular load, 13 (52%) had some type of ventricular dysfunction, and 12 (48%) had abnormal hemodynamics. For the control group, ICG showed none (0%) with elevated vascular load, none (0%) with ventricular dysfunction, and 7 (44%) with high CI. CONCLUSIONS:Prehypertensives over 40 years of age with multiple risk factors have different cardiovascular abnormalities. This ICG test could be used as part of a prevention program for early detection of CVD. An abnormal ICG test could expedite the initiation of customized treatment that targets the subclinical CVD.
Authors: T A McDonagh; C E Morrison; A Lawrence; I Ford; H Tunstall-Pedoe; J J McMurray; H J Dargie Journal: Lancet Date: 1997-09-20 Impact factor: 79.321
Authors: S P Glasser; D K Arnett; G E McVeigh; S M Finkelstein; A J Bank; D J Morgan; J N Cohn Journal: Am J Hypertens Date: 1997-10 Impact factor: 2.689
Authors: L M Resnick; D Militianu; A J Cunnings; J G Pipe; J L Evelhoch; R L Soulen; M A Lester Journal: Am J Hypertens Date: 2000-12 Impact factor: 2.689
Authors: Abdelhammed I Abdelhammed; Ronald D Smith; Pavel Levy; Gerard J Smits; Carlos M Ferrario Journal: Am J Hypertens Date: 2005-02 Impact factor: 2.689
Authors: Giuseppe Mansia; Guy De Backer; Anna Dominiczak; Renata Cifkova; Robert Fagard; Giuseppe Germano; Guido Grassi; Anthony M Heagerty; Sverre E Kjeldsen; Stephane Laurent; Krzysztof Narkiewicz; Luis Ruilope; Andrzej Rynkiewicz; Roland E Schmieder; Harry A Struijker Boudier; Alberto Zanchetti Journal: Blood Press Date: 2007 Impact factor: 2.835
Authors: Edward Koźluk; Gerard Cybulski; Agnieszka Piątkowska; Inga Zastawna; Wiktor Niewiadomski; Anna Strasz; Anna Gąsiorowska; Maciej Kempa; Dariusz Kozłowski; Grzegorz Opolski Journal: Arch Med Sci Date: 2014-12-22 Impact factor: 3.318
Authors: Bruno Silva Lopes; Nuno Craveiro; João Firmino-Machado; Pedro Ribeiro; Miguel Castelo-Branco Journal: Ther Adv Cardiovasc Dis Date: 2019 Jan-Dec